CASCADIAN

Serial Number 87012901
606

Registration Progress

Application Filed
Apr 25, 2016
Under Examination
Apr 4, 2017
Approved for Publication
Feb 7, 2017
Published for Opposition
Feb 7, 2017
Registered

Trademark Image

CASCADIAN

Basic Information

Serial Number
87012901
Filing Date
April 25, 2016
Published for Opposition
February 7, 2017
Abandonment Date
May 6, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 6, 2019
Classes
042

Rights Holder

CASCADIAN THERAPEUTICS, INC.

03
Address
2601 FOURTH AVENUE, SUITE 500
SEATTLE, WA 98121

Ownership History

Oncothyreon Inc.

Original Applicant
03
Seattle, WA

CASCADIAN THERAPEUTICS, INC.

New Owner Before Publication #1
03
SEATTLE, WA

CASCADIAN THERAPEUTICS, INC.

Owner at Publication
03
SEATTLE, WA

Legal Representation

Attorney
Clark W. Lackert

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description Documents
May 6, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 6, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jan 8, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 8, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 4, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 2, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 2, 2018 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 2, 2018 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 29, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 27, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 27, 2018 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 27, 2018 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 30, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 28, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 28, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 28, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 4, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 7, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 7, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 18, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 4, 2017 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Dec 27, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 6, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 6, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 27, 2016 ALIE A ASSIGNED TO LIE Loading...
Nov 8, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 11, 2016 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 11, 2016 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 11, 2016 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 9, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 29, 2016 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Apr 28, 2016 NWAP I NEW APPLICATION ENTERED Loading...
Apr 28, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 042
Research in the fields of pharmaceutical and biological preparations used in the diagnosis and treatment of cancer and pharmaceutical and biological preparations used in active specific immunotherapy for the treatment of cancer; providing medical and scientific research information in the fields of pharmaceuticals, biologicals, and clinical trials
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042